Minerva Neurosciences | Utile Per Azione

Prezzo Delle Azioni
6.33
Cambio Giornaliero
0.02 0.32%
Mensile
46.53%
Annuale
222.96%
Q1 Previsione
2.46

Fiscal Calendario Efettivo Consenso Precedente Data




Eps Cambiamento Data
Acadia Pharmaceuticals USD 0.42 0.26 2025-09
Adma Biologics USD 0.15 0.01 2025-09
ALKERMES USD 0.49 0.03 2025-09
Alterity Therapeutics Limited AUD 0 0 2023-12
AstraZeneca USD 2.12 0.26 2025-12
BioCryst Pharmaceuticals USD -0.13 0.06 2024-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Cipla INR 15.2 1.52 2025-12
Clal Biotechnology ILS -0.04 0.1 2022-12
Compugen USD -0.08 0 2025-09
CSL USD 2.06 2.2 2025-06
Dynavax Technologies USD 0.21 0.07 2025-09
Eli Lilly USD 7.54 0.52 2025-12
Esperion Therapeutics USD -0.15 0.18 2024-09
GlaxoSmithKline GBP 0.26 0.29 2025-12
Grifols EUR 0.26 0.06 2025-09
Halozyme Therapeutics USD 1.72 0.18 2025-09
Ionis Pharmaceuticals USD -0.8 1.5 2025-09
J&J USD 2.46 0.34 2025-12
Merck USD 2.04 0.54 2025-12
Minerva Neurosciences USD -0.56 3.53 2024-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novartis USD 2.04 0.38 2025-09
Novavax USD -0.76 1.76 2024-09
Pfizer USD 0.66 0.21 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sanofi EUR 1.53 1.38 2025-12
Takeda JPY 65.74 73.57 2025-12
Vanda Pharmaceuticals USD -0.09 0 2024-12


Minerva Neurosciences Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.